Arbutus Biopharma Corp (NAS:ABUS)
$ 3.34 -0.29 (-7.99%) Market Cap: 630.32 Mil Enterprise Value: 557.49 Mil PE Ratio: 0 PB Ratio: 5.22 GF Score: 60/100

Arbutus Biopharma Corp Annual Shareholders Meeting Transcript

May 28, 2020 / 02:00PM GMT
Release Date Price: $2.16 (-2.70%)
Operator

Ladies and gentlemen, thank you for standing by and welcome to Arbutus Biopharma Annual General Meeting Conference Call.

(Operator Instructions)

I would now like to hand the conference over to your speaker today, Bill Collier. Thank you. Please go ahead, sir.

William H. Collier
Arbutus Biopharma Corporation - President, CEO & Director

Thank you, and good morning, and welcome to Arbutus Biopharma Corporation's 2020 Annual General and Special Meeting of Shareholders. I'm Bill Collier, President and Chief Executive Officer of Arbutus, and I'll be presiding over the meeting today.

To all of our shareholders, I want to wish the best for you, your families and your communities in these uncertain unprecedented times. We're pleased to host today's meeting through this virtual meeting platform in order to ensure the health and welfare of our shareholders, directors and management in the light of the COVID-19 pandemic.

At this time, the meeting is called to order. I would first like to introduce Elizabeth Howard, Arbutus'

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot